A comprehensive nomenclature system for cyclodextrins
Modified cyclodextrins (CDs) are cyclic oligosaccharides with many applications in drug delivery, catalysis, and as active pharmaceutical ingredients. In general,
Author: szentecyclolabhu
Polyvinyl alcohol, N-acetylcysteine, and methyl-β-cyclodextrin exhibit albumin functions in natural killer cell culture
Albumin is a crucial component of serum-free media, playing a significant role in ex vivo cell culture as a lipid carrier
Mirror-Image Cyclodextrins: Actions and Interactions
A recent report of the Nobel laureate, Sir Fraser Stoddart’s team on the first synthesis of unnatural mirror-image l-cyclodextrins foreshadows a
Possible treatment of brain tuberculosis by methyl-β-cyclodextrin–assisted trans-nasal delivery of anti-tuberculosis drugs
Tuberculosis (TB) is prevalent worldwide. One of the most life-threatening manifestation of extrapulmonary tuberculosis is the involvement of central nervous
Winners of 2024 Lasker-DeBakey Clinical Medical Research Award for their pioneering works on GLP-1-based therapy for obesity
This year Lasker-De Bakey Clinical Medical Research Award honoured three scientists for their discovery and development of glucagon-like peptide-1 (GLP-1)-
Message from Prof. Takashi Hayashita (Sophia University)
The following message arrived from Prof. Takashi Hayashita: This is Takashi Hayashita (Sophia University) from the Society of Cyclodextrin, Japan
Sir Fraser Stoddart (1942-2024)
It is with deep sadness that the Cyclodextrin News shares the passing of Sir Fraser Stoddart, a Giant in the
More and more manipulated results in Alzheimer and Parkinson’s research
„Short road to discovery, winding road to use” Josef Pitha I assume that many of you remember the “story”
A new therapeutic approach to neurodegeneration? An old, known drug restarts flow of brain-cleaning fluids
On 15 August, 2024 Douglas Kelley, professor of mechanical engineering at the University of Rochester and his co-workers published that
Veklury is the first approved antiviral agent now for extended pediatric use and for those patients who are suffering in all stages of renal disease
Veklury, a SARS-CoV-2 nucleotide analog RNA polymerase inhibitor, was approved by FDA for the treatment COVID-19 in adults and pediatric